MEDICAL COLLEGES REFORM TO ADDRESS ACCESSIBILITY, AFFORDABILITY AND RURAL CHALLENGES Priority given to new trainee candidates who come from rural backgrounds and have relevant experience
With
Jodie Long, CEO
Council of Presidents of Medical Colleges (CPMC)
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Melbourne | September 2025
The Council of Presidents of Medical Colleges (CPMC) is the peak body for Australia’s specialist medical colleges. CPMC provides a voice in the areas such as workforce issues, quality of healthcare and patient safety, and the education and training of specialist doctors.
Australia’s specialist medical colleges are introducing significant changes to their training selection processes to tackle the ongoing shortage of specialist doctors in rural and remote areas. The Council of Presidents of Medical Colleges (CPMC), in collaboration with the National Rural Health Commissioner, has unveiled new guidelines that prioritise candidates with rural backgrounds and experience during trainee selection.
Associate Professor Sanjay Jeganathan, Chair of CPMC, stated, “Too many rural Australians are waiting too long for specialist care or having to travel vast distances.” Research shows that doctors from rural areas are more likely to return and practice in those communities. The new framework systematically rewards candidates with relevant rural experience, including those who spent their childhood in rural settings, medical students who completed over 12 months of rural placements, and junior doctors who worked in rural hospitals.
The initiative reflects unprecedented collaboration among Australia’s specialist medical colleges, moving from good intentions to systematic change. “Every college will now use consistent definitions and transparent processes,” added A/Prof Jeganathan.
In tandem with these changes, CPMC is reforming its governance structure to better address workforce shortages and access challenges. This revised structure includes a Representative College Council and a separate Board of Directors, promoting agile decision-making and clearer communication with stakeholders. Dr. Jeganathan emphasised the importance of creating a unified voice for specialist doctors to respond effectively to urgent healthcare reforms, enhancing the organisation’s accountability and responsiveness.
Australian Health Journal spoke to CPMC CEO Jodie Long about some of the findings and challenges in the workforce within regional and rural settings and how the new governance structure will support representation of the 16 colleges to Government bodies.
Source: Adapted from CPMC media releases
-
Foundation outlines breast cancer research strategy
Australian Health Journal met with Associate Professor Cleola Anderiesz, CEO of the National Breast Cancer Foundation to hear of the new 5 year Pink Horizon research strategy. Those with lived experience of breast cancer, along with researchers, clinicians, and other funding organisations, have contributed to the development of the foundation’s new five-year Pink Horizon research strategy. This ambitious plan aims to invest $125 million to accelerate research efforts towards the vision of ending deaths from breast cancer.
-
Interventional radiologists offer alternative to hysterectomy
In Australia in the last five years, an estimated 6066 women per year have undergone hysterectomies to treat fibroid-related diseases, while just 145 women each year have undergone a uterine artery embolisation, or UAE.
The procedure can effectively treat the majority of bleeding uterine fibroids. Each year, thousands of Australian women undergo invasive and life-altering hysterectomies to treat debilitating pain and blood loss caused by uterine fibroids. But there’s another option: a minimally invasive, pin-hole procedure that treats the symptoms, yet leaves the uterus intact.
-
Making clinical trials participant friendly
Clinical trials are essential in developing new, improved, and more effective treatments and interventions. Without trials, researchers and professionals in the field cannot properly determine whether these new treatments and interventions are safe and effective.
The Clinials platform is geared towards patient centric trials and reducing site burden. The aim is to accelerate lifesaving medicines coming to market by connecting participants and researchers. The platform allows participants to come to researchers with their eligibility in hand among other capabilities.
